Display Settings:

Format

Send to:

Choose Destination
    Hautarzt. 2002 Sep;53(9):587-95.

    [Role of matrix-degrading enzymes in melanoma progression].

    [Article in German]

    Source

    Universitätsklinik und Poliklinik für Hautkrankheiten, Julius-Maximilians Universität, Würzburg, Germany. uta.hofmann@mail.uni-wuerzburg.de

    Abstract

    Cutaneous melanoma is an invasive and early metastazising tumor. Melanoma cells detach from the primary tumor, penetrate the basement membrane, invade lymphatics and blood vessels, and form metastases. These processes all depend on coordinated expression and/or activation of proteolytic enzymes. In addition to aspartyl- and cysteineproteinases, serine proteinases including the plasminogen activator system (uPA, uPAR, tPA, PAI-1 and PAI-2) and matrix metalloproteinases (MMPs) with their tissue inhibitors (TIMPs) play an essential role in these processes. In addition, melanoma cells require specific adhesion molecules such as integrins and CD44 for interaction with other cells and components of the extracellular matrix (ECM); these are also involved in binding activated MMPs on the cell surface. In this review we discuss these functional aspects of melanoma progression.

    PMID:
    12207262
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Springer

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk